Carmine Therapeutics Company
Carmine Therapeutics is developing novel types of gene therapies that utilize extracellular vesicles (EVs) produced in the laboratory.
Founded Date:
2019
Headquarters:
Cambridge, Massachusetts, United States
Technology:
Cardiovascular Disorders
Industry:
Gene Therapy
Estimated Revenue:
$1M to $10M
Funding Status:
Seed